These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 20412395

  • 1. Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis.
    Antulov R, Carone DA, Bruce J, Yella V, Dwyer MG, Tjoa CW, Benedict RH, Zivadinov R.
    J Neuroimaging; 2011 Jul; 21(3):210-8. PubMed ID: 20412395
    [Abstract] [Full Text] [Related]

  • 2. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [Abstract] [Full Text] [Related]

  • 3. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS.
    Carone DA, Benedict RH, Dwyer MG, Cookfair DL, Srinivasaraghavan B, Tjoa CW, Zivadinov R.
    Neuroimage; 2006 Jan 15; 29(2):505-14. PubMed ID: 16169253
    [Abstract] [Full Text] [Related]

  • 4. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep 15; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 5. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K, Kuster P, Traud S, Egger H, Winklhofer S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Matthews PM, Nichols TE, Radue EW, Borgwardt SJ.
    Neuroimage; 2009 Mar 01; 45(1):60-7. PubMed ID: 19013533
    [Abstract] [Full Text] [Related]

  • 6. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B.
    Neurology; 2005 Jul 26; 65(2):280-5. PubMed ID: 16043800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis.
    Bendfeldt K, Kappos L, Radue EW, Borgwardt SJ.
    J Neurol Sci; 2009 Oct 15; 285(1-2):268-9; author reply 269. PubMed ID: 19500803
    [No Abstract] [Full Text] [Related]

  • 13. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R.
    Mult Scler; 2013 Oct 15; 19(11):1485-92. PubMed ID: 23462349
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.
    Int Rev Neurobiol; 2007 Oct 15; 79():521-35. PubMed ID: 17531857
    [Abstract] [Full Text] [Related]

  • 17. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
    Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M, Zorzon M.
    Mult Scler; 2007 May 15; 13(4):490-501. PubMed ID: 17463072
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.